These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 27143948)
21. Utilization, patency, and complications associated with vascular access for hemodialysis in the United States. Arhuidese IJ; Orandi BJ; Nejim B; Malas M J Vasc Surg; 2018 Oct; 68(4):1166-1174. PubMed ID: 30244924 [TBL] [Abstract][Full Text] [Related]
22. Antifungal catheter lock therapy for the management of a persistent Candida albicans bloodstream infection in an adult receiving hemodialysis. Paul DiMondi V; Townsend ML; Johnson M; Durkin M Pharmacotherapy; 2014 Jul; 34(7):e120-7. PubMed ID: 24782326 [TBL] [Abstract][Full Text] [Related]
23. Prospective, randomized study of long-term hemodialysis catheter removal versus guidewire exchange to treat catheter-related bloodstream infection. Saleh HM; Tawfik MM; Abouellail H J Vasc Surg; 2017 Nov; 66(5):1427-1431.e1. PubMed ID: 28822660 [TBL] [Abstract][Full Text] [Related]
24. Locking Hemodialysis Catheters With Trimethoprim-Ethanol-Ca-EDTA to Prevent Bloodstream Infections: A Randomized, Evaluator-blinded Clinical Trial. Rijnders B; DiSciullo GJ; Csiky B; Rutkowski B; Appelt K; Cheronis J; Aitchison R; Gordon G; Jadoul M; Fluck R Clin Infect Dis; 2019 Jun; 69(1):130-136. PubMed ID: 30281074 [TBL] [Abstract][Full Text] [Related]
25. Ethanol lock and risk of hemodialysis catheter infection in critically ill patients. A randomized controlled trial. Souweine B; Lautrette A; Gruson D; Canet E; Klouche K; Argaud L; Bohe J; Garrouste-Orgeas M; Mariat C; Vincent F; Cayot S; Cointault O; Lepape A; Guelon D; Darmon M; Vesin A; Caillot N; Schwebel C; Boyer A; Azoulay E; Bouadma L; Timsit JF Am J Respir Crit Care Med; 2015 May; 191(9):1024-32. PubMed ID: 25668557 [TBL] [Abstract][Full Text] [Related]
26. A vancomycin-heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective, randomized trial. Garland JS; Alex CP; Henrickson KJ; McAuliffe TL; Maki DG Pediatrics; 2005 Aug; 116(2):e198-205. PubMed ID: 15995005 [TBL] [Abstract][Full Text] [Related]
27. Citrate versus heparin lock for prevention of hemodialysis catheter-related complications: updated systematic review and meta-analysis of randomized controlled trials. Mai H; Zhao Y; Salerno S; Li Y; Feng Y; Ma L; Fu P Int Urol Nephrol; 2019 Jun; 51(6):1019-1033. PubMed ID: 31012037 [TBL] [Abstract][Full Text] [Related]
28. Generalized and Prolonged Use of Gentamicin-Lock Therapy Reduces Hemodialysis Catheter-Related Infections Due to Gram Negatives. Padilla-Orozco M; Mendoza-Flores L; Herrera-Alonso A; Garza González E; Gutiérrez Ferman JL; Rodríguez-López JM; Bocanegra-Ibarias P; Camacho-Ortiz A Nephron; 2019; 143(2):86-91. PubMed ID: 31203289 [TBL] [Abstract][Full Text] [Related]
29. A randomized trial comparing gentamicin/citrate and heparin locks for central venous catheters in maintenance hemodialysis patients. Moran J; Sun S; Khababa I; Pedan A; Doss S; Schiller B Am J Kidney Dis; 2012 Jan; 59(1):102-7. PubMed ID: 22088576 [TBL] [Abstract][Full Text] [Related]
30. Catheter-related infections in children treated with hemodialysis. Paglialonga F; Esposito S; Edefonti A; Principi N Pediatr Nephrol; 2004 Dec; 19(12):1324-33. PubMed ID: 15378418 [TBL] [Abstract][Full Text] [Related]
31. Usefulness of endoluminal catheter colonization surveillance cultures to reduce catheter-related bloodstream infections in hemodialysis. Brañas P; Morales E; Ríos F; Sanz F; Gutiérrez E; Quintanilla N; Orellana MA; Sánchez M; Rodríguez-Aranda A; Chaves F Am J Infect Control; 2014 Nov; 42(11):1182-7. PubMed ID: 25248485 [TBL] [Abstract][Full Text] [Related]
32. Outcomes of the First and Second Hemodialysis Fistula: A Cohort Study. Kamar F; Quinn RR; Oliver MJ; Viecelli AK; Hiremath S; MacRae J; Miller L; Blake P; Moist L; Garg AX; Lam NN; Kabani R; Clarke A; Liu P; Gillespie B; Ravani P Am J Kidney Dis; 2019 Jan; 73(1):62-71. PubMed ID: 30122545 [TBL] [Abstract][Full Text] [Related]
33. Antimicrobial lock solutions as a method to prevent central line-associated bloodstream infections: a meta-analysis of randomized controlled trials. Zacharioudakis IM; Zervou FN; Arvanitis M; Ziakas PD; Mermel LA; Mylonakis E Clin Infect Dis; 2014 Dec; 59(12):1741-9. PubMed ID: 25156111 [TBL] [Abstract][Full Text] [Related]
35. Cefazolin-gentamicin versus taurolidine-citrate for the prevention of infection in tunneled central catheters in hemodialysis patients: A quasi-experimental trial. Bueloni TNV; Marchi D; Caetano C; de Souza Cavalcante R; Mendes Amaral ML; Ponce D Int J Infect Dis; 2019 Aug; 85():16-21. PubMed ID: 31102823 [TBL] [Abstract][Full Text] [Related]
36. Central venous catheters and biofilms: where do we stand in 2017? Gominet M; Compain F; Beloin C; Lebeaux D APMIS; 2017 Apr; 125(4):365-375. PubMed ID: 28407421 [TBL] [Abstract][Full Text] [Related]
37. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report]. Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265 [TBL] [Abstract][Full Text] [Related]
38. The impact of catheter-restricted filling with cefotaxime and heparin on the lifespan of temporary hemodialysis catheters: a case controlled study. Saxena AK; Panhotra BR J Nephrol; 2005; 18(6):755-63. PubMed ID: 16358235 [TBL] [Abstract][Full Text] [Related]